TAYLORVILLE, Ill., Sept. 16, 2007

Gene Therapy Death Draws Scrutiny

Investigators Examine A Woman's Sudden Fatal Illness For Links To A Clinical Trial

  •  (CBS/iStockphoto)

  • Quiz Arthritis Quiz

    Test your knowledge about this widespread and painful ailment.

(AP)  A few hours before she died this summer at the age of 36, Jolee Mohr lay in a Chicago hospital so swollen by internal bleeding and her failing kidneys that her husband decided against bringing their 5-year-old daughter to say goodbye. The girl wouldn't have recognized her mother.

Robb Mohr couldn't bring himself to watch her die and he spent his wife's last hours talking with her helpless and puzzled doctors. One vowed to get to the bottom of the illness, and there were several clues to go on.

The most unusual was this: Jolee Mohr fell ill the day after her right knee was injected with trillions of genetically engineered viruses in a voluntary experiment to find out if gene therapy might be a safe way to ease the pain of rheumatoid arthritis. She was dead three weeks later.

The sponsor of this nationwide experiment, Targeted Genetics Corp. of Seattle, has halted the work and more than 125 patients are being evaluated, according to a company spokeswoman. No other problems have been reported, and the company believes patients were adequately informed of the treatment's risks.

U.S. health officials are investigating Mohr's death, and the case is expected to be discussed Monday by advisers to the National Institutes of Health. There's a lot at stake, including answers for Robb Mohr, and the interests of Targeted Genetics. But there are also questions about how medical studies are done and how much study volunteers are told of the risks.

"To me, it's an avoidable death," Mohr said during an interview at his home amid the cornfields of central Illinois. "And you're going to have to really show me a lot of stuff to convince me that it wasn't."

There have been more than 800 gene therapy studies involving 5,000 U.S. patients since the NIH approved the nation's first human gene transfer study in 1989. Yet there are no approved therapies despite 17 years of research, and the only major success - a cure for the rare inherited immune disorder known as "bubble boy disease" - came with a high cost: leukemia linked in 2003 to the virus that delivered the treatment.

Still, the 1999 death of Arizona teenager Jesse Gelsinger is the only reported fatality definitively linked with a U.S. gene therapy study, an NIH spokesman said. And Dr. Theodore Friedmann, who once headed the NIH committee that oversees gene therapy experiments, said developments in medicine often come with problems, even death.

Even if gene therapy is found to be the cause of Jolee Mohr's death, Friedmann said, the method remains promising.

"There's no question that this event is tragic for the family and the woman involved," he said. "It does simply point to the fact that we have a lot more to learn."

--

When Dr. Robert Trapp of the Arthritis Center in Springfield told Jolee Mohr about the gene therapy study, she had lived with rheumatoid arthritis for 14 years, her husband said. She kept the pain, stiffness and swelling in her joints under control with medication.

Mohr seldom missed any work at her full-time data entry job for the Illinois secretary of state. She went to church and volunteered at the county fair. She loved to read and work in her garden. She and Robb had just bought a boat and were planning to build a new house. Their only child, Toree, was getting ready for kindergarten.

To enroll in the study, every patient had to have some form of inflammatory arthritis. Jolee Mohr had faith in Trapp, her doctor for seven years, her husband said.

"You trust your physician. He's your doctor. You trust him like you do your minister," Robb Mohr said.

Jolee Mohr thought the experimental treatment might relieve the chronic pain in her right knee, her husband said, though this stage of the study was simply to find out if the treatment was safe. Bioethicists talk of a "therapeutic misconception" - a belief among patients in early-stage research that they will get better.

Robb Mohr said his wife believed.

Jolee Mohr signed a 15-page consent form Feb. 12. "Knowing her, she probably didn't read through it," her husband said.

The form mentioned some scary possibilities. It said that the genetically altered viruses in the study - called tgAAC94 - "could spread to other parts of your body. The risks of this are not known at this time."

"We have seen this type of spread in animal studies when tgAAC94 has been given by injection into the joint," the form said.

Altered viruses can "damage the DNA in the cells of your body by inserting itself into your genes," it went on. "If this happens, it could put you at risk for developing cancer in the future."

And on page 9, it said unknown side effects could result in "pain, discomfort, disability or, in rare circumstances, death."

Continued



© MMVII The Associated Press. All Rights Reserved. This material may not be published, broadcast, rewritten, or redistributed.
Share:
  • Share
  • Yahoo! Buzz
  • Mixx
Add a Comment
by gordon.couger September 16, 2007 10:42 PM EDT
I think next year will be my 50th year with Multiple Sclerosis. I am really lucky at it goes years between attacks. I had to drop out of typing in 1957 when I went from 30 WPM with 2 errors on Friday to 5 wpm with 7 error then next Monday. At little of the speed came back but with out a computer I would still be a functional illerate when it comes to writing. For it did far worse to my handwriting.

I did mange to get a BS degree, barely. It never bothered me again until 1981 when I lost all feeling of pain in my right side and nearly lost the use of my left leg in two weeks. The problems and pain have got slowly worse ever since.

For a 1 in 125 chance of dying next month over a 1 in 10, 1 in 20 or maybe any chance in stopping the down hill road I am on all I want to know is where to I sign up and I will pay my own parking and good deal more.

For some one with MS I do really well I am still on my feet all the time I need a cane very rarely. I can take enough anti-inflammatory drugs and pain killers to do most anything I want for a few day if I am willing to pay the price for a week or two.

In all life there is risk. There is no progress without it. The only thing I know that is risk free is a casket. Then only to the correctly embalmed occupant. If you want to be risk free there is your ride. I am not ready to make up that load yet.

GC
Reply to this comment
by michellem99-2009 September 16, 2007 5:54 PM EDT
THE DOCTOR
By Barbara Ann
They go to school.
Graduate and licensed.
They are people.
Yet some are so backwards.
They put money first.
Asked them something.
They say I don''t know.
What did they teach him/her.
Docter is human.
Write medicines.
No idea what they will do.
Each person is different.
There are good doctors.
They must not be greedy.
Live the fancy life.
Be the healers of the body.
Do no harm.

please give Barbara Ann the credit if you use the verse.
Reply to this comment
by Krazcarl September 16, 2007 1:55 PM EDT
This the dawning of a new age in medicne there will be causualties that''s why it''s experimental. The unfortunat thing about research is that you learn from mistakes. I''m on my third artifical hip due to arthritis if I could have had a few shots clear it up that would have saved me countless misery.
Reply to this comment
by slim1h2o September 16, 2007 12:43 PM EDT
You trust your physician. He''s your doctor. You trust him like you do your minister," Robb Mohr said.

Ha what a laugh er, Your doctor doesn;t squat about medicine,,,,That''s why they call it "Practicing Medicine"

It''s time to re evaluate the medical industry in this country
Reply to this comment
  • MOST POPULAR
Latest News
News in Pictures
Scroll Left Scroll Right
Connect with CBS News

Stay connected with the CBS News using your favorite social networks and online news applications: